Expression of concern

Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases

Paper Information

Record ID:
19935
Publication Date:
October 20, 2016
Retraction Date:
February 06, 2019 (6.8 years years ago)
Article Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Expression of concern Details

Nature of Retraction:

Expression of concern

Retraction Notice:
10.1186/s40169-019-0222-0

Citations (4)

4
Total Citations
0
Post-Retraction
1
Pre-Retraction
1
Same Day
Paper citing Clinical study of Gene-Eden-VIR/Novirin in genital...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Clinical study of Gene-Eden-VIR/Novirin in genital...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Clinical study of Gene-Eden-VIR/Novirin in genital...
Unknown Authors
Unknown Journal
Published: Feb 2019
Same day as retraction
Paper citing Clinical study of Gene-Eden-VIR/Novirin in genital...
Unknown Authors
Unknown Journal
Published: Mar 2017
707 days before retraction
Quick Stats
Total Citations: 4
Years Since Retraction: 6.8 years
Open Access: Yes
Last Checked: Never
Related Papers
Combined rs-fMRI study on brain functional imaging and mech…
Clinical and Translational Medicine • 10 citations
CD248 as a novel therapeutic target in pulmonary arterial h…
Clinical and Translational Medicine • 11 citations
Deceptology in cancer and vaccine sciences: Seeds of immune…
Clinical and Translational Medicine • 6 citations
Purified umbilical cord derived mesenchymal stem cell treat…
Clinical and Translational Medicine • 6 citations
Evaluation of patients with multiple sclerosis using revers…
Clinical and Translational Medicine • 6 citations